Return to: Department of Pediatrics : Medical School : Academic Health Center : myU : U of M Home

Gold University of Minnesota M. Skip to main content. Link to University of Minnesota homepage
Division of Hematology and Oncology, Department of Pediatrics
Whats Inside
For Patients & Families

Research

Faculty and Staff

News & Events

Contact Us

Education

Resources

 

Peds HEMONC Home


University Pediatrics Foundation - Make a Gift

Viking Children's Fund

Children's Cancer Research Fund

Department of Pediatrics > Hematology and Oncology > Faculty and Staff > Michael J. Burke, M.D.

Printer-friendly version   Mail this page to a friend

Michael J. Burke, M.D.


Dr. Michael Burke

Assistant Professor
Mayo Mail Code 484
420 Delaware Street, S.E.
Minneapolis, MN 55455
Phone: 612-626-2778
Fax: 612-626-2815
burke283@umn.edu
Preferred method of contact: email

Dr. Burke is an Assistant Professor in the Division of Pediatric Hematology/Oncology/Blood and Marrow Transplantation in the Department of Pediatrics.  He received his bachelor’s degree in Biological Sciences at the University of California at Irvine, in Irvine, California.  Dr. Burke attended Ross University School of Medicine in Dominica, where he received his M.D. degree in 2000.  Following medical school he completed a Pediatric residency at the Medical College of Virginia- Virginia Commonwealth University in Richmond, Virginia and a fellowship in Pediatric Hematology/Oncology/Blood and Marrow Transplantation at Children’s Memorial Hospital- Northwestern University Feinberg School of Medicine. 

In addition to the care of children, Dr. Burke is particularly interested in the treatment of childhood leukemia and lymphoma.

Honors and Awards

  • 2000 Magna Cum Laude, Ross University School of Medicine

Research Interests

  1. Childhood leukemia
  2. Relapsed ALL

Selected Recent Publications

Burke MJ, Walterhouse DO, Jacobsohn DA, Duerst RE, Kletzel M. Tandem high dose chemotherapy with autologous peripheral hemtopoietic progenitor cell rescue as consolidation for high risk Ewing's Sarcoma. Pediatric Blood and Cancer. January 9, 2007.

Burke MJ, Cohn SL. Rituximab for treatment of Opsoclonus-myoclonus syndrome in neuroblastoma. Pediatric Blood and Cancer. 2006 Aug 9.


Feedback | Notice of Privacy Practices


 
The University of Minnesota is an equal opportunity educator and employer.